CJC-1295 Without DAC and Ipamorelin Dosage: A Research Guide

The typical CJC-1295 without DAC and ipamorelin dosage is 100 mcg of each peptide per injection, taken one to three times per day. Most protocols keep both compounds at a 1:1 ratio, for a total of 100-300 mcg of each per day. Neither peptide is FDA-approved for human use in the United States, so these figures describe research practice rather than a prescribed medical regimen.

Why CJC-1295 Without DAC Is Stacked With Ipamorelin

CJC-1295 without DAC is a modified growth hormone-releasing hormone (GHRH) analog, often labeled mod GRF 1-29. Ipamorelin is a selective growth hormone secretagogue that works through the ghrelin receptor. Each compound triggers growth hormone release through a different pathway.

Because the two receptors do not compete, research models show a larger and more physiological growth hormone pulse when both peptides are present. CJC-1295 without DAC clears the body in roughly 30 minutes, which is why a fast-acting secretagogue like ipamorelin is added to the same protocol.

Standard CJC-1295 Without DAC and Ipamorelin Dosage

Reported CJC-1295 and ipamorelin dosage protocols cluster into three tiers. The table below describes what researchers and users report, not what a clinician would prescribe.

Protocol tier	Per injection	Injections per day	Total daily (each peptide)	Typical use
Starting	100 mcg	1	100 mcg	First exposure and tolerance check
Standard	100 mcg	2	200 mcg	Most common in research logs
Higher	100-150 mcg	3	300-450 mcg	Advanced only, more side-effect risk

Amounts above 300 mcg of each peptide per day have no support in controlled human data. Staying near the bottom of the range reduces the odds of water retention and joint achiness that show up in user reports.

Injection Timing and Frequency

Growth hormone is released in pulses, mainly during deep sleep and after hard training. Placing doses inside those windows is the standard approach.

• Before bed. A dose 30-60 minutes before sleep mimics the natural nocturnal pulse.
• Around training. A second injection is often timed before or after a workout.
• Fasted. Carbohydrates blunt the growth hormone response, so injections are usually kept 2-3 hours away from food.
• Same slots daily. A consistent schedule keeps the pulse pattern predictable.

Reconstitution Math for Blend Vials

A cjc-1295 no dac ipamorelin 10mg blend dosage question almost always refers to one vial holding 5 mg of CJC-1295 without DAC and 5 mg of ipamorelin. A vial sold as cjc-1295 without dac 5mg ipamorelin 5mg is the same 1:1 blend. Because both peptides share the vial, a single injection delivers an equal amount of each.

Vial contents	Bacteriostatic water added	Concentration (each peptide)	Volume for a 100 mcg dose	Units on a U-100 syringe
5 mg + 5 mg	2 mL	2.5 mg/mL	0.04 mL	4 units
5 mg + 5 mg	3 mL	1.67 mg/mL	0.06 mL	6 units
5 mg + 5 mg	5 mL	1 mg/mL	0.10 mL	10 units

The math is simply the target dose divided by the concentration. Because a 100 mcg draw is often under 0.1 mL, insulin syringes with half-unit markings are common. Larger 10 mg blends follow the same calculation and only change the volume drawn.

CJC-1295 With DAC or Without: Key Differences

Anyone comparing cjc-1295 ipamorelin with dac or without is really choosing between a short pulse and a sustained level. DAC stands for Drug Affinity Complex, a modification that lets CJC-1295 bind to albumin and extends its half-life from about 30 minutes to roughly 6-8 days.

• Without DAC: short-acting, injected 1-3 times daily, produces distinct pulses, and is the version normally paired with ipamorelin.
• With DAC: long-acting, injected weekly or every few days, keeps growth hormone elevated around the clock instead of in waves.

CJC-1295 with DAC stays active for roughly 6-8 days, while CJC-1295 without DAC clears in about 30 minutes. Continuous elevation is a different physiological state than pulsatile release. Round-the-clock growth hormone exposure is associated with more fluid retention, higher insulin resistance, and a greater burden on the pituitary axis than brief daily pulses.

What Users Report vs. What Research Shows

Interest in a cjc-1295 without dac dosage bodybuilding protocol comes from online logs, not from controlled trials. Users commonly describe better sleep, faster recovery, and small changes in body composition across 8-12 weeks, though those reports are unblinded and frequently mixed with other compounds.

No large human trial has measured body composition outcomes for this specific stack, so anecdotal results cannot establish cause and effect. Forum threads about cjc-1295 ipamorelin dosage per day reddit typically return a dozen different answers, which suggests the community is guessing as much as measuring.

Side Effects and Safety Considerations

Commonly reported side effects include injection-site irritation, headache, flushing, mild water retention, vivid dreams, and increased appetite. Most complaints are mild and ease when the dose is lowered or the frequency is reduced.

The bigger questions involve long-term growth hormone elevation. Chronic GH excess is linked with insulin resistance, joint swelling, carpal tunnel symptoms, and faster growth of existing tumors. People with a history of cancer, diabetes, or pituitary disease have the strongest reasons to avoid these peptides.

Neither CJC-1295 without DAC nor ipamorelin is FDA-approved for human use in the United States, and no dose of either peptide has been proven safe or effective in controlled human trials.

Baseline blood work and periodic monitoring of IGF-1, fasting glucose, and HbA1c are the practical way to track how the body responds. A healthcare professional familiar with peptide research can help interpret those results and flag problems early.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical CJC-1295 without DAC and ipamorelin dosage per day?

Most research protocols use 100 mcg of CJC-1295 without DAC plus 100 mcg of ipamorelin per injection, one to three times daily. That equals 100 to 300 mcg of each peptide per day. Neither peptide is FDA-approved for human use, and no controlled trial has confirmed a safe or effective human dose.

Should CJC-1295 with DAC or without DAC be paired with ipamorelin?

Ipamorelin is almost always paired with the without-DAC version because both compounds act in short pulses that mimic natural growth hormone release. CJC-1295 with DAC stays active for about a week and keeps growth hormone elevated continuously, which is a different pattern and raises more concern about long-term GH exposure.

What time of day should CJC-1295 and ipamorelin be injected?

The most common timing is 30 to 60 minutes before bed on an empty stomach, with an optional second dose around training. Injections are usually kept at least two to three hours away from meals because food, especially carbohydrates, blunts the growth hormone response. A consistent daily schedule matters more than hitting one perfect clock time.